F.D.A. Approves Weight-Loss Drug to Treat Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition.
Read more at The New York Times
Topics
-
FDA approves weight loss drug Zepbound for sleep apnea
Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said.NBC News - 4h -
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.CNBC - 4h -
Eli Lilly given US approval to treat sleep disorder with weight-loss drug
Regulatory go-ahead marks latest boost for drugmaker’s blockbuster anti-obesity franchiseFinancial Times - 4h -
Weight Loss Drugs Changed Their Lives. Then They Lost Coverage.
In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.The New York Times - 1d -
What other conditions could weight-loss drugs treat?
Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’sFinancial Times - Dec. 12 -
Some health experts warn against microdosing weight loss drugs
The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some ...CBS News - Dec. 9 -
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.CNBC - Dec. 8 -
Weight-loss drug Mounjaro 'changed my life,' says mother-of-two
People struggling with their weight welcome the NHS rollout of Mounjaro but worry about delays.BBC News - Dec. 5 -
Millions will have to wait up to 12 years for NHS weight-loss drug
Fears that giving 3.4 million people immediate access to new weight-loss drug could overwhelm NHS.BBC News - Dec. 5
More from The New York Times
-
The Republicans Who Defied Trump on the Spending and Debt Deal
The New York Times - 6h -
G.O.P. Spending Hawks Defy Trump on the Debt Limit, Previewing More Clashes
The New York Times - 2h -
Driver Rams Into Christmas Market in Germany, Killing at Least 2 and Injuring Dozens
The New York Times - 1h -
Trump Moves to Replace Officials Whom New Presidents Traditionally Leave Alone
The New York Times - 4h -
In Late Push, Senate Democrats Narrowly Top Trump on Judicial Confirmations
The New York Times - 2h